In this issue of newsDAY various thought leaders from Chiltern weigh in on the complex, global issues that surround drug development today.
- Global Diagnostics Approval
- Bringing MMAs to Market
- Risk-Based Monitoring
- The Role of a CRO
Read more about these issues to gain a better understanding of how to successfully navigate the changing research environment